Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate.
Freemantle
N
N
Medicines Evaluation Group, Centre for Health Economics, University of York, York YO10 5DD.
Mason
J
J
D000047:Academies and Institutes; D017277:Drug Approval / Q000458:organization & administration*; D016527:Drug Costs; D004345:Drug Industry; D011367:Professional Staff Committees; D015397:Program Evaluation; D019057:Quality-Adjusted Life Years; D013222:State Medicine / Q000592:standards; D006113:United Kingdom